Markets Review: Beazley shares leap as vaccine cheer persists

Shares in London-listed Beazley surged over 20 percent last week to lead widespread gains for European P&C stocks as most sectors and major indices advanced on the prospect of an effective coronavirus vaccine.

 

Want to read this article?

 

For details on how to subscribe or for all commercial opportunities, including advertising, please contact:

Andy Stone

Sales manager

+44 (0) 77 4160 9204

andy.stone@thomsonreuters.com

    Ricky Lamey

    Business development executive

    ricky.lamey@thomsonreuters.com